The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELX.L Regulatory News (ELX)

  • There is currently no data for ELX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM and Proposal

30 Nov 2018 15:04

RNS Number : 0957J
El Oro Ltd
30 November 2018
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA OR THE REPUBLIC OF SOUTH AFRICA

 

EL ORO LIMITED ("COMPANY")

Registration No: 49778

 

30 November 2018

 

 

Notice of Annual General Meeting and Proposal for the Future of the Company

 

The Company has today published the notice of its Annual General Meeting, which is also copied below, and details of a new proposal that the board of the Company ("Board") is exploring as an alternative to a liquidation of the Company. This proposal, to be entered into with JPMorgan Elect plc ("JPME") ("JPME Proposal") would offer a real choice to the Company's members ("Members") of cashing out or rolling over into a larger investment company with access to greater investment resource. This may offer greater flexibility to Members in terms of tax planning.

 

The Board has remained conscious of the concerns expressed by Members during 2016. These included the investment performance of the Company, the lack of liquidity in the Ordinary Shares and their widening discount to net asset value. These concerns were described in the Chairman's letter giving notice of the annual general meeting of the Company held on 17 November 2016. The Board has studied a wide range of options for the future direction of the Company, having regard to the fact that the concerns referred to above remain.

 

The Board is pleased to announce that it has agreed heads of terms with the board of JPME for JPME to provide a "rollover" option for Members. JPME provides investors access to a number of different investment strategies, including one focussed on UK equity income, through a multi-share class structure and the Board believe this will appeal to Members. 

 

JPME, which has total net assets of £369.6 million (as at 31 August 2018), has three share classes, and quarterly conversion between share classes is permitted. The investment objectives of the three classes, which the Board considers to be comparable to the Company's overall investment objective, are set out below:

 

· Managed Income - A growing income return with potential for long term capital growth by investing in equities, investment companies and fixed income securities (the "Income Shares").

· Managed Growth - Long term capital growth from investing in a range of investment trusts and open-ended funds managed principally by JPMorgan Asset Management (the "Growth Shares").

· Managed Cash - Preservation of capital with a yield based on short term interest rates (the "Cash Shares").

 

The Board expects that each of the above share classes will be made available as rollover options for Members, with JPME Managed Income being the default. Each share class is listed separately and traded on the main market of the London Stock Exchange and JPME's shareholders are able to switch between the three share classes on a quarterly basis without incurring a liability to UK capital gains tax.

 

Members who want to rollover their El Oro Shares in a cost and tax efficient way can choose to rollover into new JPME shares.

 

Members who want to exit for cash with broadly the same amounts as they would have received on simple liquidation can choose the cash option.

 

Subject to final agreements being signed with JPME, the Board currently anticipates that appropriate circulars will be issued to Members during the first calendar quarter of 2019, with the restructuring likely to be completed before June 2019. Under the proposed restructuring of the Company (as currently envisaged), Members will be asked to vote on the proposals.

 

Further information on JPME and full details of the terms of the JPME Proposal will be included in the documentation to be sent to Members in 2019. However, Members are also encouraged to visit the website of JPME at:

 

https://am.jpmorgan.com/gb/en/asset-management/gim/per/products/investment-trusts/jpm-elect-plc 

 

NOTICE OF ANNUAL GENERAL MEETING

 

NOTICE IS HEREBY GIVEN that the Company's NINTH ANNUAL GENERAL MEETING and theONE HUNDRED AND FOURTEENTH ANNUAL GENERAL MEETING OF THE EL ORO GROUP will be held on 20 December 2018 at 41 Cheval Place, London SW7 1EW at 12 noon for the following purposes:

 

Ordinary resolutions:

 

1. To receive the Directors' report and the consolidated financial statements for the year ended 30 June 2018.

 

2. To re-appoint PricewaterhouseCoopers CI LLP as Auditor of the Company, to hold office until the conclusion of the next General Meeting at which financial statements are laid before the Company and to authorise the Directors to fix their remuneration.

 

3. To ratify the payment of a final dividend of 2.54 pence for the year ended 30 June 2018.

 

4. To authorise the Company generally and unconditionally to make market purchases within the meaning of Section 315 of the Companies (Guernsey) Law 2008, the authority for market acquisitions set forth in Article 4.7 of the Company's Articles of Incorporation be approved and restated on the basis that of its Ordinary Shares in the capital of the Company ("Shares") upon or subject to the following conditions:

 

(a) the maximum number of Shares hereby authorised to be purchased is 6,317,340;

 

(b) the maximum price at which Shares may be purchased shall be 5% above the average of the middle market quotations for the Shares as taken from The International Stock Exchange Daily Official List for the five Business Days preceding the date of purchase and the minimum price shall be 5 pence per share, in both cases exclusive of expenses; and

 

(c) the authority to purchase conferred by this Resolution shall expire on the date falling eighteen months after the date of this resolution or at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution, save that the Company may before such expiry enter into a contract of purchase under which such contract may be completed or executed wholly or partly after the expiration of this authority.

 

 

The Board recommends that Members vote in favour of all ordinary resolutions.

 

A copy of this notice and the accompanying circular to Members is available on the Company's website: www.eloro.com.

 

For further information, please contact:

 

El Oro Ltd www.eloro.com 020 7581 2782

Robin Woodbine Parish, Chairman

Una Ni Dhonaill

 

Aztec Financial Services (Guernsey) Limited 01481 748831

Chris Copperwaite

 

 

Registered address: East Wing,

Trafalgar Court,

Les Banques,

St Peter Port, GY1 3PP

 

End of announcement

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAEADFEDAKPFFF
Date   Source Headline
2nd Jul 20199:00 amRNSResult of Scheme of Reconstruction
20th Jun 20193:00 pmRNSResult of EGM
14th Jun 20191:30 pmRNSScheme Timetable Update
14th Jun 201912:00 pmRNSGroup Portfolio List of Investments
24th May 20195:00 pmRNSPublication of Circular
13th May 20196:08 pmRNSNet Asset Value
8th May 201912:00 pmRNSCancellation of Shares
1st May 201912:00 pmRNSUpdate on Proposals
24th Apr 20192:00 pmRNSNet Asset Value
16th Apr 20192:30 pmRNSGroup Portfolio List of Investments
1st Apr 201912:30 pmRNSHalf-year Report
15th Mar 201912:00 pmRNSNet Asset Value
25th Feb 20193:00 pmRNSNet Asset Value(s)
4th Feb 201911:30 amRNSGroup Portfolio List of Investments
20th Dec 20183:30 pmRNSResult of AGM
14th Dec 20183:00 pmRNSNet Asset Value(s)
30th Nov 20183:04 pmRNSNotice of AGM and Proposal
16th Nov 20183:30 pmRNSNet Asset Value(s)
12th Nov 20184:00 pmRNSCancellation of Treasury Shares
15th Oct 20183:30 pmRNSNet Asset Value(s)
3rd Oct 20183:30 pmRNSDividend Declaration
3rd Oct 20183:30 pmRNSAnnual Financial Report
28th Sep 20185:00 pmRNSNet Asset Value(s)
16th Aug 20185:00 pmRNSNet Asset Value(s)
6th Aug 20184:00 pmRNSNet Asset Value(s)
3rd Jul 20184:30 pmRNSNet Asset Value(s)
25th May 20183:00 pmRNSEU GDPR Data Privacy Notice
18th May 20184:00 pmRNSNet Asset Value(s)
20th Apr 20184:30 pmRNSNet Asset Value(s)
19th Mar 20184:00 pmRNSNet Asset Value(s)
15th Mar 201811:45 amRNSHalf-year Report
14th Feb 20184:00 pmRNSNet Asset Value(s)
17th Jan 20183:00 pmRNSNet Asset Value(s)
5th Jan 20184:30 pmRNSDirector/PDMR Shareholding
21st Dec 20173:00 pmRNSKey Information Document
15th Dec 20173:30 pmRNSNet Asset Value(s)
16th Nov 20171:42 pmRNSResult of AGM
16th Nov 201710:00 amRNSNet Asset Value(s)
13th Oct 20173:00 pmRNSNet Asset Value(s)
5th Oct 20173:00 pmRNSNet Asset Value(s)
26th Sep 20175:30 pmRNSNotice of AGM
26th Sep 20175:30 pmRNSAnnual Report & Accounts
26th Sep 20175:30 pmRNSDividend Declaration
11th Aug 20173:00 pmRNSNet Asset Value(s)
27th Jul 20173:00 pmRNSNet Asset Value(s)
19th Jun 20174:00 pmRNSNet Asset Value(s)
26th May 20175:00 pmRNSDirector/PDMR Shareholding
10th May 20173:00 pmRNSNet Asset Value(s)
2nd May 20173:00 pmRNSDirector/PDMR Shareholding
19th Apr 20174:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.